Si se acerca la hora de la siguiente dosis, sltese la dosis omitida
High BMI Your doctor may prescribe GLP-1 drugs if you have a high body mass index (BMI) of 30 or more
Delivery of bioactive gene particles via gelatin-collagen-peg-based electrospun matrices
Frequently Asked Questions Can I keep taking metformin when I start semaglutide

Common Side Effects Dry persistent cough Hypotension Dizziness Hyperkalemia Taste disturbance (metallic taste) Serious Adverse Effects Angioedema (life-threatening) Severe hyperkalemia Acute kidney injury Neutropenia (rare) Contraindications Pregnancy (teratogenic) Bilateral renal artery stenosis History of ACE inhibitor-induced angioedema Drug Interactions Avoid combination with: Potassium supplements Potassium-sparing diuretics (spironolactone) NSAIDs (reduce effect + kidney risk) Other antihypertensives (risk of hypotension) Monitoring Parameters Blood pressure Serum potassium Serum creatinine Renal function Counseling Points Take 1 hour before meals (better absorption) Do not stop suddenly Report swelling of face/lips immediately Avoid potassium-rich salt substitutes Dry cough is common Clinical Pearls First ACE inhibitor developed Short-acting requires multiple daily dosing If patient develops cough switch to ARB (like Losartan) Useful in diabetic patients for kidney protection Summary Captopril is a short-acting ACE inhibitor effective for hypertension and heart failure but requires careful monitoring due to risks of cough, hyperkalemia, and angioedema

General timeline: Week 12 at a new dose: Nausea most likely, especially after meals Week 34: Symptoms usually begin to ease noticeably Week 5+: Most users report little to no nausea at a stable dose Dose increase: The cycle may restart briefly at a lower intensity Common mistake: Stopping tirzepatide entirely after the first wave of nausea, before the body has had time to adjust